Access cutting-edge covid-19 treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
The primary objective of the Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) (INSIGHT 012) trial is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo among adults with recently diagnosed severe acute respiratory syndrome - coronavirus 2 (SARS-CoV2) infection who do not require hospitalization. The primary endpoint of this double-blind randomized trial is a five-category ordinal outcome that asse
Sponsor: University of Minnesota
Check if you qualify for this covid-19 clinical trial in Tucson, AZ
If you're searching for covid-19 treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.